Bloom Energy heads into its May 7 earnings report having more than doubled in a month — a move that has forced nearly every analyst covering the stock to rethink their numbers.
The price action is the story. Shares closed at $290.52 on Friday, up 114% in a month and 26% in the past week alone. That surge followed a 23% one-day jump after the prior earnings release on April 28, and it has left the stock trading above most revised price targets. JP Morgan lifted its target to $267 and RBC Capital moved to $335, but even that most-bullish call sits below where shares trade today. Citigroup, maintaining its Neutral rating, only just raised to $281 — still below the current price. The broad pattern: analysts are raising targets aggressively, yet the stock has already outrun the consensus mean of $230.75. The market has priced in a bullish scenario before the numbers arrive.
Options traders are more cautious than the price action implies. The put/call ratio has climbed to 1.12, more than two standard deviations above its 20-day average of 0.94, reaching the highest level of the past year. That signals heavier demand for downside protection — investors are hedging a stock that has run hard into the print, not simply adding exposure with conviction.
Short sellers are retreating, not pressing. Short interest has fallen 10% in a week to 9.1% of the float, after running near 11% earlier in April. Borrow costs remain negligible at 0.43%, and availability is loose, meaning there is no meaningful squeeze pressure fuelling the rally. The move is driven by buyers, not forced covering.
The bull case centres on data-centre demand and Bloom's expanding backlog in clean, distributed power — a theme that has driven the stock since late April. EPS momentum ranks in the 99th percentile, and forward earnings estimates have climbed sharply. Bears point to a stretched valuation: the stock trades at 104x earnings and 52x book value, and the company has issued $2.5 billion in zero-coupon convertible notes that will dilute shareholders if the price holds above roughly $185. Insiders have offered their own signal — the COO, Chief Legal Officer, and Acting CFO all sold material stakes in March and April, collectively unloading tens of millions in stock as the rally accelerated.
The May 7 print is therefore a test of whether Bloom's fundamentals can justify a valuation that its own analysts, even the most bullish, have not yet caught up to.
See the live data behind this article on ORTEX.
Open BE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
